Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pinverin to Reduce Bowel FDG Uptake in Cancer Patients
NCT02173964Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pinaverium in cancer (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Standardized Uptake Value. Started Jul 2014; status: completed.
02
Drugs
pinaverium
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02173964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173964.